Full text is available at the source.
Abstract
Chronic recreational ketamine abuse has been linked to cholestasis and cholangiopathy.
- The safety profile of ketamine and esketamine for treatment-resistant depression is not well understood.
- There is a concern that therapeutic use of these substances may pose similar risks to liver health as seen in recreational use.
- Current knowledge lacks systematic data on liver enzyme changes or biliary injury associated with subanesthetic doses used in depression treatment.
Simplified